Although numerous antigens have been identified as potential targets (e.g., Trop2, GD2, ROR1, MUC1, EpCAM), the ideal target should represent the most relevant obstacle, thereby minimizing on-target/off-tumor toxicities and reducing tumor escape via antigen loss and intrinsic heterogeneity [65,66]. This evidence concerns the gene ROR1 and neoplasm.